Experimental and spontaneous metastasis assays can result in divergence in clonal architecture

[1]  S. Naik,et al.  Mastering the use of cellular barcoding to explore cancer heterogeneity , 2022, Nature Reviews Cancer.

[2]  K. Rogers,et al.  Spatial omics and multiplexed imaging to explore cancer biology , 2021, Nature Methods.

[3]  Melissa J. Davis,et al.  The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile , 2021, Science Advances.

[4]  N. Turner,et al.  Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment , 2021, Nature Cancer.

[5]  K. Roarty,et al.  Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis , 2021, Frontiers in Oncology.

[6]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[7]  Ted E. Natoli,et al.  A metastasis map of human cancer cell lines , 2020, Nature.

[8]  Jeffrey T. Chang,et al.  Methodological Advancements for Investigating Intra-tumoral Heterogeneity in Breast Cancer at the Bench and Bedside , 2020, Journal of Mammary Gland Biology and Neoplasia.

[9]  Jeffrey S. Damrauer,et al.  Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence , 2020, Nature Communications.

[10]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[11]  K. Powell,et al.  Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging. , 2020, Journal of visualized experiments : JoVE.

[12]  S. Merajver,et al.  Heterogeneity at the invasion front of triple negative breast cancer cells , 2020, Scientific Reports.

[13]  Yan Lin,et al.  Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice , 2020, Scientific Reports.

[14]  I. Okano,et al.  Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts , 2020, Journal of Mammary Gland Biology and Neoplasia.

[15]  Maxwell P. Lee,et al.  Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures , 2019, Molecular Cancer Research.

[16]  Maria C. Lecca,et al.  Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts , 2019, Proceedings of the National Academy of Sciences.

[17]  F. Hollande,et al.  Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer. , 2019, Biochemical Society transactions.

[18]  Daniel L. Cameron,et al.  Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer , 2019, Nature Communications.

[19]  Shan Jiang,et al.  Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors. , 2019, Cell reports.

[20]  Jeffrey T. Chang,et al.  High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer , 2018, Nature Communications.

[21]  N. Shomron,et al.  Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness , 2018, Cell Death & Disease.

[22]  A. Abarrategi,et al.  Clonal dynamics in osteosarcoma defined by RGB marking , 2018, Nature Communications.

[23]  Joshua M. Dempster,et al.  Genetic and transcriptional evolution alters cancer cell line drug response , 2018, Nature.

[24]  O. Tawfik,et al.  MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis , 2018, PloS one.

[25]  Gan‐Lin Zhang,et al.  Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation , 2018, Oncology letters.

[26]  François Vaillant,et al.  Patient-derived xenograft (PDX) models in basic and translational breast cancer research , 2016, Cancer and Metastasis Reviews.

[27]  G. MacGrogan,et al.  The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours , 2016, The Journal of pathology.

[28]  A. Wardley,et al.  Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis , 2016, Journal of Mammary Gland Biology and Neoplasia.

[29]  Wassim Raffoul,et al.  A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response. , 2016, Cancer cell.

[30]  M. Hirst,et al.  Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells , 2015, Nature.

[31]  Z. Werb,et al.  The Cleared Mammary Fat Pad Transplantation Assay for Mammary Epithelial Organogenesis. , 2015, Cold Spring Harbor protocols.

[32]  Steffen Dickopf,et al.  A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis , 2015, Nature.

[33]  Martin Hirst,et al.  DNA barcoding reveals diverse growth kinetics of human breast tumour subclones in serially passaged xenografts , 2014, Nature Communications.

[34]  T. Schumacher,et al.  Cellular barcoding: a technical appraisal. , 2014, Experimental hematology.

[35]  Dawen Zhao,et al.  Ultrasound imaging-guided intracardiac injection to develop a mouse model of breast cancer brain metastases followed by longitudinal MRI. , 2014, Journal of visualized experiments : JoVE.

[36]  T. Schumacher,et al.  Diverse and heritable lineage imprinting of early haematopoietic progenitors , 2013, Nature.

[37]  L. Ellis,et al.  Intraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies. , 2013, Cancer letters.

[38]  S. Milstien,et al.  Is tail vein injection a relevant breast cancer lung metastasis model? , 2013, Journal of thoracic disease.

[39]  F. Kittrell,et al.  An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ , 2009, Breast Cancer Research.

[40]  Ruth J. Muschel,et al.  A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth , 2009, PloS one.

[41]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[42]  Gerhard Christofori,et al.  Mouse models of breast cancer metastasis , 2006, Breast Cancer Research.

[43]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[44]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[45]  K. Hunter,et al.  Modeling metastasis in vivo. , 2004, Carcinogenesis.

[46]  H. Bern,et al.  Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. , 1959, Cancer research.

[47]  P. Ordóñez-Morán,et al.  An Intrasplenic Injection Model for the Study of Cancer Stem Cell Seeding Capacity. , 2020, Methods in molecular biology.

[48]  Sang Joon Kim,et al.  A Mathematical Theory of Communication , 2006 .

[49]  Christopher W. Wong,et al.  Apoptosis: an early event in metastatic inefficiency. , 2001, Cancer research.